PTC Therapeutics, Inc. (PTCT) vs Scholar Rock Holding Corporation (SRRK)
- PTC Therapeutics, Inc. PTCT 59.24 −2.87%
- Scholar Rock Holding Corporation SRRK 39.85 −1.94%
PTC Therapeutics, Inc. and Scholar Rock Holding Corporation are both Biotechnology companies. PTC Therapeutics, Inc. and Scholar Rock Holding Corporation are of similar size ($5.1B and $5.0B). Scholar Rock Holding Corporation grew revenue faster over the last twelve months: 213.7% against −42.8%. Scholar Rock Holding Corporation has the higher net margin (0.00% vs −3.80%) and the lower return on invested capital (0.00% vs 15.2%). Across the 16 metrics below, PTC Therapeutics, Inc. leads on 10 and Scholar Rock Holding Corporation on 6.
Valuation
Profitability
| Metric | PTCT | SRRK | Biotechnology median |
|---|---|---|---|
| Gross margin | 92.99% | 0.00% | 65.16% |
| Operating margin | 12.45% | 0.00% | 0.00% |
| Net margin | (3.80%) | 0.00% | 0.00% |
| Free cash flow margin | (29.76%) | 0.00% | 0.00% |
| Return on equity | 20.64% | (167.77%) | (56.36%) |
| Return on assets | (1.30%) | (94.63%) | (48.04%) |
| Return on invested capital | 15.16% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack